Literature DB >> 23909401

Collaboration of AMPK and PKC to induce phosphorylation of Ser413 on PIP5K1B resulting in decreased kinase activity and reduced PtdIns(4,5)P2 synthesis in response to oxidative stress and energy restriction.

Iman van den Bout1, David R Jones, Zahid H Shah, Jonathan R Halstead, Willem-Jan Keune, Shabaz Mohammed, Clive S D'Santos, Nullin Divecha.   

Abstract

The spatial and temporal regulation of the second messenger PtdIns(4,5)P2 has been shown to be crucial for regulating numerous processes in the cytoplasm and in the nucleus. Three isoforms of PIP5K1 (phosphatidylinositol 4-phosphate 5-kinase), A, B and C, are responsible for the regulation of the major pools of cellular PtdIns(4,5)P2. PIP5K1B is negatively regulated in response to oxidative stress although it remains unclear which pathways regulate its activity. In the present study, we have investigated the regulation of PIP5K1B by protein phosphorylation. Using MS analysis, we identified 12 phosphorylation sites on PIP5K1B. We developed a phospho-specific antibody against Ser413 and showed that its phosphorylation was increased in response to treatment of cells with phorbol ester, H2O2 or energy restriction. Using inhibitors, we define a stress-dependent pathway that requires the activity of the cellular energy sensor AMPK (AMP-activated protein kinase) and PKC (protein kinase C) to regulate Ser413 phosphorylation. Furthermore, we demonstrate that PKC can directly phosphorylate Ser413 in vitro. Mutation of Ser413 to aspartate to mimic serine phosphorylation decreased both PIP5K1B activity in vitro and PtdIns(4,5)P2 synthesis in vivo. Our studies show that collaboration between AMPK and PKC dictates the extent of Ser413 phosphorylation on PIP5K1B and regulates PtdIns(4,5)P2 synthesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909401     DOI: 10.1042/BJ20130259

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  6 in total

1.  A genome-wide association study for harness racing success in the Norwegian-Swedish coldblooded trotter reveals genes for learning and energy metabolism.

Authors:  Brandon D Velie; Kim Jäderkvist Fegraeus; Marina Solé; Maria K Rosengren; Knut H Røed; Carl-Fredrik Ihler; Eric Strand; Gabriella Lindgren
Journal:  BMC Genet       Date:  2018-08-29       Impact factor: 2.797

Review 2.  The Plasma Membrane: A Platform for Intra- and Intercellular Redox Signaling.

Authors:  Daniela E Nordzieke; Iria Medraño-Fernandez
Journal:  Antioxidants (Basel)       Date:  2018-11-20

3.  Multiomics analysis profile acute liver injury module clusters to compare the therapeutic efficacy of bifendate and muaddil sapra.

Authors:  Ainiwaer Talifu; Refuhati Saimaiti; Yusufu Maitinuer; Geyu Liu; Miernisha Abudureyimu; Xuelei Xin
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

4.  Construction of Prognostic Risk Prediction Model of Oral Squamous Cell Carcinoma Based on Nine Survival-Associated Metabolic Genes.

Authors:  Zhen-Dong Huang; Yang-Yang Yao; Ting-Yu Chen; Yi-Fan Zhao; Chao Zhang; Yu-Ming Niu
Journal:  Front Physiol       Date:  2021-03-16       Impact factor: 4.566

5.  Theragnostic chromosomal rearrangements in treatment-naive pancreatic ductal adenocarcinomas obtained via endoscopic ultrasound.

Authors:  Stephen J Murphy; Michael J Levy; James B Smadbeck; Giannoula Karagouga; Alexa F McCune; Faye R Harris; Julia B Udell; Sarah H Johnson; Sarah E Kerr; John C Cheville; Benjamin R Kipp; George Vasmatzis; Ferga C Gleeson
Journal:  J Cell Mol Med       Date:  2021-03-11       Impact factor: 5.310

6.  The carbonic anhydrase inhibitor acetazolamide inhibits urinary bladder cancers via suppression of β-catenin signaling.

Authors:  Taisuke Matsue; Min Gi; Masayuki Shiota; Hirokazu Tachibana; Shugo Suzuki; Masaki Fujioka; Anna Kakehashi; Tomoki Yamamoto; Minoru Kato; Junji Uchida; Hideki Wanibuchi
Journal:  Cancer Sci       Date:  2022-07-02       Impact factor: 6.518

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.